TY - JOUR
T1 - KAT6A Syndrome
T2 - genotype–phenotype correlation in 76 patients with pathogenic KAT6A variants
AU - The DDD Study,
AU - Kennedy, Joanna
AU - Goudie, David
AU - Blair, Edward
AU - Chandler, Kate
AU - Joss, Shelagh
AU - McKay, Victoria
AU - Green, Andrew
AU - Armstrong, Ruth
AU - Lees, Melissa
AU - Kamien, Benjamin
AU - Hopper, Bruce
AU - Tan, Tiong Yang
AU - Yap, Patrick
AU - Stark, Zornitza
AU - Okamoto, Nobuhiko
AU - Miyake, Noriko
AU - Matsumoto, Naomichi
AU - Macnamara, Ellen
AU - Murphy, Jennifer L.
AU - McCormick, Elizabeth
AU - Hakonarson, Hakon
AU - Falk, Marni J.
AU - Li, Dong
AU - Blackburn, Patrick
AU - Klee, Eric
AU - Babovic-Vuksanovic, Dusica
AU - Schelley, Susan
AU - Hudgins, Louanne
AU - Kant, Sarina
AU - Isidor, Bertrand
AU - Cogne, Benjamin
AU - Bradbury, Kimberley
AU - Williams, Mark
AU - Patel, Chirag
AU - Heussler, Helen
AU - Duff-Farrier, Celia
AU - Lakeman, Phillis
AU - Scurr, Ingrid
AU - Kini, Usha
AU - Elting, Mariet
AU - Reijnders, Margot
AU - Schuurs-Hoeijmakers, Janneke
AU - Wafik, Mohamed
AU - Blomhoff, Anne
AU - Ruivenkamp, Claudia A.L.
AU - Nibbeling, Esther
AU - Dingemans, Alexander J.M.
AU - Douine, Emilie D.
AU - Nelson, Stanley F.
AU - Newbury-Ecob, Ruth
PY - 2019/4/1
Y1 - 2019/4/1
N2 - Purpose: Pathogenic variants in KAT6A have recently been identified as a cause of syndromic developmental delay. Within 2 years, the number of patients identified with pathogenic KAT6A variants has rapidly expanded and the full extent and variability of the clinical phenotype has not been reported. Methods: We obtained data for patients with KAT6A pathogenic variants through three sources: treating clinicians, an online family survey distributed through social media, and a literature review. Results: We identified 52 unreported cases, bringing the total number of published cases to 76. Our results expand the genotypic spectrum of pathogenic variants to include missense and splicing mutations. We functionally validated a pathogenic splice-site variant and identified a likely hotspot location for de novo missense variants. The majority of clinical features in KAT6A syndrome have highly variable penetrance. For core features such as intellectual disability, speech delay, microcephaly, cardiac anomalies, and gastrointestinal complications, genotype– phenotype correlations show that late-truncating pathogenic variants (exons 16–17) are significantly more prevalent. We highlight novel associations, including an increased risk of gastrointestinal obstruction. Conclusion: Our data expand the genotypic and phenotypic spectrum for individuals with genetic pathogenic variants in KAT6A and we outline appropriate clinical management.
AB - Purpose: Pathogenic variants in KAT6A have recently been identified as a cause of syndromic developmental delay. Within 2 years, the number of patients identified with pathogenic KAT6A variants has rapidly expanded and the full extent and variability of the clinical phenotype has not been reported. Methods: We obtained data for patients with KAT6A pathogenic variants through three sources: treating clinicians, an online family survey distributed through social media, and a literature review. Results: We identified 52 unreported cases, bringing the total number of published cases to 76. Our results expand the genotypic spectrum of pathogenic variants to include missense and splicing mutations. We functionally validated a pathogenic splice-site variant and identified a likely hotspot location for de novo missense variants. The majority of clinical features in KAT6A syndrome have highly variable penetrance. For core features such as intellectual disability, speech delay, microcephaly, cardiac anomalies, and gastrointestinal complications, genotype– phenotype correlations show that late-truncating pathogenic variants (exons 16–17) are significantly more prevalent. We highlight novel associations, including an increased risk of gastrointestinal obstruction. Conclusion: Our data expand the genotypic and phenotypic spectrum for individuals with genetic pathogenic variants in KAT6A and we outline appropriate clinical management.
KW - genetic diagnosis
KW - KAT6A syndrome; chromatin modifiers; intellectual disability
KW - phenotypic spectrum
UR - http://www.scopus.com/inward/record.url?scp=85053824960&partnerID=8YFLogxK
U2 - 10.1038/s41436-018-0259-2
DO - 10.1038/s41436-018-0259-2
M3 - Article (Academic Journal)
C2 - 30245513
AN - SCOPUS:85053824960
SN - 1098-3600
VL - 21
SP - 850
EP - 860
JO - Genetics in Medicine
JF - Genetics in Medicine
IS - 4
ER -